ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).
| Image |  |
|---|---|
| Description | scientific article published on 17 July 2017 |
| Author/s |
author: Mark McKeage Byoung Chul Cho Alastair Peter Greystoke Evaristo Maiello Gloria Borra Alessandra Bearz |
| Publication date | July 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |